Streamlining Radiation Oncology Prior Authorization with Da Vinci PAS

The Challenge of Prior Authorization in Radiation Oncology

Radiation oncology treatments frequently require prior authorization due to their complexity, high cost, and the need for precision. Procedures such as Intensity-Modulated Radiation Therapy (IMRT), proton beam therapy, Stereotactic Body Radiation Therapy (SBRT), and brachytherapy are common PA triggers. Historically, this has involved navigating disparate payer portals like Availity or UHCprovider.com, submitting clinical documentation via fax or as unstructured PDFs, and deciphering inconsistent payer responses, leading to significant administrative overhead and potential treatment delays.

Transforming Rad Onc PA with Da Vinci PAS Standards

Klivira's platform integrates Da Vinci PAS (Prior Authorization Support) to standardize and automate the PA workflow for radiation oncology. By leveraging HL7 FHIR R4 and the Da Vinci PAS IG, we move beyond legacy X12 278 transactions that rely on referenced attachments, enabling structured clinical data exchange. This shift significantly reduces manual effort, accelerates decision-making, and improves the consistency of PA submissions and responses for high-volume rad onc procedures.

Klivira's Da Vinci PAS Workflow for Radiation Oncology

• **Pre-PA Coverage Discovery (Da Vinci CRD)**: At the point of order entry in the EMR, Klivira uses Da Vinci CRD to identify PA requirements for treatments like IMRT or proton beam therapy, providing real-time insights into payer policies.
• **Structured Documentation Assembly (Da Vinci DTR)**: For payers supporting Da Vinci DTR, clinical questionnaires are presented and automatically populated from EMR FHIR data, ensuring all necessary documentation (e.g., staging, treatment plans, clinical rationale aligning with NCCN or ACR guidelines) is complete and structured.
• **Standardized PAS Submission**: Klivira constructs a FHIR `Claim` resource with the `$submit` operation, bundling structured clinical documentation as `DocumentReference` and related FHIR resources, then submits it to the payer's PAS endpoint.
• **Consistent Response Handling**: Payer responses, whether approval, denial, or pending, are received as `ClaimResponse` resources. Klivira normalizes these into a consistent workflow state within the EMR, regardless of the specific payer's code set.
• **Status Tracking and EMR Integration**: Klivira tracks pending authorizations through inquiry operations or webhook events. The final decision, including authorization numbers and conditions, is written back to the EMR's order record, streamlining the handoff to scheduling and billing.

Addressing Common Prior Authorization Failure Modes

In radiation oncology, Klivira's Da Vinci PAS implementation directly addresses critical inefficiencies. It replaces the need for per-payer custom integrations with a uniform FHIR operation interface, streamlining maintenance. The platform ensures clinical documentation, often complex for therapies like SBRT, is submitted as structured FHIR resources rather than unstructured PDFs, enabling faster payer-side review. Furthermore, inconsistent response semantics from various payers are normalized, providing a clear, standardized workflow state for your team.

Navigating the Evolving Regulatory Landscape

The regulatory environment, notably CMS-0057-F, mandates impacted payers (Medicare Advantage, Medicaid managed-care, CHIP managed-care, QHP-on-FFM) to implement a Prior Authorization API by January 1, 2027, aligning with Da Vinci PAS conformance. Klivira actively tracks payer conformance status and routes authorizations accordingly, utilizing PAS endpoints where available and falling back to X12 278 or portal submissions for non-conformant payers. This ensures your radiation oncology department is prepared for current and future PA requirements.